TrialDiabetes care2022

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes.

Juraj Koska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.